2022 Pilot Program and Feasibility Projects – Application
Type 1 and Type 2 Applications consist of:
- Cover page: PI name and title, institutional affiliation and address, title of the proposal, application type (Type 1 or Type 2), start and end date, and total budget requested (direct+indirect);
- An NIH-format Biosketch for the PI;
- Research project description (4 page maximum, including figures). References may be included in additional page(s). Project descriptions should include the project aims; background and significance to understanding the social determinants of health and aging; proposed data collection and analysis plan; timeline; and a statement of potential paths to independent funding. Preliminary data are allowed, but not required. Descriptions should address standard NIH criteria regarding power, rigor, reproducibility, and consideration of sex as a biological variable. A letter of support should be included if collaboration with, or facilities and data belonging to, other researchers are essential to the project’s success;
- Budget and budget justification (1 page);
- Additional documents, where applicable: If the applicant is a post-doc, a letter of support from the post-doctoral mentor is required. If the applicant is an established investigator (i.e., not an early stage or new investigator, per NIH’s definition: https://grants.nih.gov/grants/glossary.htm), a short (<1 page) justification of how the pilot would support a new, previously unfunded area of research in animal models and the social dimensions of aging is required.
The full application packet, saved in a single pdf file named “Lastname.Firstname.Type[1 or 2].2022.pdf” should be submitted electronically no later than October 11, 2022.
Budget and additional requirements: The budget for all applications is limited to a maximum of $20,000 in total costs. The maximum administrative duration of the award will be 12 months, with a start date on or before February 1, 2023 conditional on any necessary IACUC/IRB approvals. Sub-awards to other institutions are not allowed.
Applications will be accompanied by a 1-page budget and budget justification. At the application stage, the budget does not need to be institutionally approved by your research support/grants and contracts office; this will occur if the pilot is awarded. General NIH guidelines for allowable expenses should be followed. Eligible costs include travel and accommodation, consumables, animals and per diem, other direct costs for data generation and data analysis, and use of core facilities, and salary support.
For Type 1 Mentored Projects, the awards will be issued as a subaward to the selected training site (Duke, UNC or UMN) or to the PI’s institution based on individual project structure. The budget justification should also include a description of the target host institution and any core facilities/services/data access requirements that will be incorporated into the pilot project. For Type 2 independent Projects, the award will be issued as a subaward to the PI institution and the PI will be fully responsible for the administration of the award, the execution of the project, securing IACUC/IRB approval, etc.
Review of applications and funding priorities: Applications will be reviewed by the Research Network PIs, members of the Advisory Board, and ad hoc reviewers with appropriate expertise. The highest priority applications will i) describe a highly novel and impactful project that would be feasible within the proposed funding timeline and benefit from early-stage pilot funding and ii) will clearly articulate the value of the proposed research for research on the social determinants of health and aging.
Report of activity and Acknowledgements: The PI must provide a final report of activities pursued under the award to the Research Network leadership, no later than two months after the award end date. Publications, presentations, or material disclosed to the public domain should be reported to the Network PIs for dissemination and reporting purposes, and should acknowledge support from NIH/NIA R24 AG065172.